Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer

Annals of Oncology

Volumn 5, Issue 7, 1994, Pages 591-595

  Semiglazov, V E ^a   Topuzov, E E ^a   Bavli, J L ^a   Moiseyenko, V M ^a   Ivanova, O A ^a   Seleznev, I K ^a   Orlov, A A ^a   Barash, N Y ^a   Golubeva, O M ^a   Chepic, O F ^a  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

Author keywords

Breast cancer; Neoadjuvant chemotherapy; Radiotherapy

Indexed keywords

FLUOROURACIL; METHOTREXATE; THIOTEPA;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENTERITIS; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PHASE 3 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMATITIS; SURVIVAL;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FLUOROURACIL; HUMANS; MASTECTOMY, MODIFIED RADICAL; METHOTREXATE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; THIOTEPA;

EID: 0028048459     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a058929     Document Type: Article

References (0)